When the World Health Organization declared the Bundibugyo ebolavirus outbreak spanning Uganda and the Democratic Republic of the Congo a global health emergency in May, scientists at Dalhousie University in Halifax joined an international network of researchers racing to understand a newly identified genetic variant for which no approved vaccines or treatments existed. Working from genomic sequences generated by local teams in both countries, they mapped the virus's mutations and used computational modeling to identify remdesivir — a drug first deployed during COVID-19 — as a promising candid
Researchers identify new Ebola variant, propose repurposed drug treatment
Ebola outbreak in Uganda and DRC declared a Public Health Emergency of International Concern, affecting populations in both countries.